A A-a 1. Okita M, Nakano J, Kataoka H, Sakamoto J, Origuchi T, Yoshimura T. Effects of therapeutic ultrasound on joint mobility and collagen fibril

Transcription

1 A A-a 1. Okita M, Nakano J, Kataoka H, Sakamoto J, Origuchi T, Yoshimura T. Effects of therapeutic ultrasound on joint mobility and collagen fibril arrangement in the endomysium of immobilized rat soleus muscle. Ultrasound Med Biol 35 (2): , (IF:2.395 ) 2. Nakano J, Kataoka H, Sakamoto J, Origuchi T, Okita M, Yoshimura T. Low-level laser irradiation promotes the recovery of atrophied gastrocnemius skeletal muscle in rats. Exp Physiol 94 (9): , (IF:2.910 ) 3. Inoue T, Suzuki S, Hagiwara R, Iwata M, Banno Y, Okita M: Effects of passive stretching on muscle injury and HSP expression during recovery after immobilization in rats. Pathobiology 76: , (IF: 1.818) 4. Sakamoto J, Origuchi T, Okita M, Nakano J, Kato K, Yoshimura T, Izumi S, Komori T, Nakamura H, Ida H, Kawakami A, Eguchi K. Immobilization-induced cartilage degeneration mediated through expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and chondromodulin-i. Connect Tissue Res 50 (1): 37-45, (IF:1.113 ) 5. Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Tsurumoto T, Kono M, Shindo H, Ida H, Origuchi T, Eguchi K: Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs. J Rheumato. 36 (11): , (IF:3.282 ) 6. Aramaki T, Kawakami A, Iwamoto N, Fujikawa K, Kawashiri SY, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Nakashima M, Mizokami A, Furuyama M, Matsuoka N, Ueki Y, Ida H, Origuchi T, Aoyagi K, Eguchi K: Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables. Mod Rheumatol 19 (6): 652-6,. 7. Ida H, Aramaki T, Nakamura H, Fujikawa K, Arima K, Tamai M, Kamachi M, Satoh K, Origuchi T, Kawakami A, Furuichi I, Kawabe Y, Eguchi K: Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis. Cytotechnology ;60 (1-3): 161-4, (IF:0.875 ) 8. Iwamoto N, Kawakami A, Fujikawa K, Aramaki T, Kawashiri SY, Tamai M, Arima K, Ichinose K, Kamachi M, Yamasaki S, Nakamura H, Nakashima M, Mizokami A, Goto A, Fukuda T, Matsuoka N, Ueki Y, Tsukada T, Migita K, Shoumura F, Kawabe Y, Shibatomi K, Mine M, Ida H, Origuchi T, Aoyagi K, Eguchi K: Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population. Mod Rheumatol 19 (5): ,. 9. Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K: A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 61 (6): 772-8, (IF:6.787 ). 10. Fujikawa K, Kawakami A, Tamai M, Uetani M, Takao S, Arima K, Iwamoto N, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K: High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion. J Rheumatol 36 (6): , (IF:3.282 ) 11. Fujikawa K, Kawakami A, Kaji K, Fujimoto M, Kawashiri S, Iwamoto N, Aramaki T, Ichinose K, Tamai M, Kamachi M, Nakamura H, Ida H, Origuchi T, Ishimoto H, Mukae H, Kuwana M, Kohno S, Takehara K, Sato S, Eguchi K: Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kda polypeptides, anti-140-kda polypeptides, and anti-aminoacyl trna synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumato 38 (4): 263-7, (IF:2.345 ) 12. Aramaki T, Ida H, Izumi Y, Fujikawa K, Huang M, Arima K, Tamai M, Kamachi M, Nakamura H, Kawakami A, Origuchi T, Matsuoka N, Eguchi K: A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Mod Rheumatol 19 (3): ,. 13. Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima K, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Eguchi K. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies. J Rheumatol 36 (1): 113-5, (IF:3.282 ) 14. Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H: Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 68 (8):1310-5, (IF:7.188 ) 15. Igawa K, Manabe Y, Oyamada J, Kitagawa1 Y, Kato K, Ikematsu K, Nakasono I, Matsushita T, RokutandaA: Mitochondrial DNA analysis of Yayoi period human skeletal remains from the Doigahama site, Journal of Human Genetics54: ,. (IF:2.431) 16. Yoza Y, Ariyoshi K, Honda S, Taniguchi H, Senjyu H. Development of an activity of daily living scale for patients with COPD: The activity of daily living dyspnoea scale. Respirology 14: , 17. Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by legionella pneumophila. J Infect 59: , 1

2 A-b 1. Inokuchi S, Nakahara K, Matsusaka N: Improvements of muscle strength and balance function of physically frail elderly people after intervention of a nurse-led community exercise programme for prevention of falls-changes of the strength and function-. Communications to the Autumn Meeting of the British Geriatrics Society Programme of Abstracts. pp44, 2. Nakahara K, Matsusaka N, Inokuchi S: Effectiveness of volunteers in a community-based health promotion for frail elderly people change of physical function and psychological status of volunteers (The 2nd report). The 7th East Asian Congress of Health Promotion (EACHP). pp97-98, 3. Nakahara K, Inokuchi S, Matsusaka N: Effectiveness of a community exercise programme for physically frail elderly people assisted by healthy older volunteers-effective and efficient Intervention through volunteers-. Communications to the Autumn Meeting of the British Geriatrics Society Programme of Abstracts. pp43, B B-a 1. 36: 33-40, 2. IIII mrna 12(1)11-15, 3. PCB PCQPCDF 100(5) ,,,,,,,,,,,, QOL. RA 23: 24-28, 5.,,,,,,,,,,, Churg-Strauss (1): 22-32, 6.,,,,,,,,,,,,,. 32 (3): , 7., 122: 25-30, 8.,,,,. 11:7-14, 9.,,,,,? ,,,,,,, COPD 11-Q. 19:43-47, 11.,,, Nagasaki university endurance shuttle walking test. 19: , 12.,,,,,. 7: , 13.,,,, COPD. 47: , 14.,,,,,,,? : 25-30, B-b 1. 26(9): , 2. 26(5) , 3. PT 43(7) , Supplement (1): 181, Supplement (2) DVD: 92, 6. 2

3 36 Supplement (2) DVD: 254, Supplement (2) DVD: 1293, Supplement (2) DVD: 1294, Supplement (2) DVD: 1298, Supplement (3): 34, (1): 26, (1): 30, (1): 33, (1): 38, 15. PAIN RESEARCH 24(2): 28, 16. PAIN RESEARCH 24(2): 72, (8): S1169, : 70-71, 19.,,,,,,,,,,,,,,,,,,, , 20.,,,,,,,,,,,,,,,,, IgG4 75 IgG4+MOLPS IgG4 Mikulicz , 21.,, COPD copd. 57: , 22., COPD. Journal of Clinical Rehabilitation 18: , 23. COPD COPD. 86: , : , 25. book 1 rst!. : , 26.,,, EBPT. 36: , 27.? 28: , Supplement (2) DVD: Supplement (2) DVD Supplement: S392, (1) (1) Supplement (2) DVD , 3

4 35.,, Wavelet 11: ,,, 36 Supplement (2) DVD: 124, 37.,,,,, 36 Supplement (2) DVD: 222, 38., 36 Supplement (2) DVD: 241, 39.,,,, 36 Supplement (2) DVD: 391, 40.,,,, 36 Supplement (2) DVD: 394, 41.,,,, () 36 Supplement (2) DVD: 1549, 42. PT 43(9)803 B-c : 3, 3. 2 : 7, 4. 2 : 13, : 11, 6. pp ,. (,,, (), 9,,, pp ) 8.,, X. ((),,, pp.2-5 ) 9.,, MRI. ((),,, pp.6-31 ) 10.,,. ((),,, pp ) pp pp , : 11, pp pp pp B-d 1.,,,,, A. 22(1): 25-32, (2)1-17, 3.,,,.. 21:29-33, 4. 4

5 , (2), 85-92, 5., CK : 85-89, Aa Ab Ba Bb

6 5 42 () C B 6

7 VEGF RS3PE B COPD COPD B B C C MuSK C QOL 7

8 8